Clinical Trials Logo

Clinical Trial Summary

Adductory spasmodic dysphonia (AdSD) is a rare condition characterised by irregular and uncontrolled voice interruptions, most commonly affecting women around the age of 45. The diagnosis is clinical and usually requires evaluation by several specialists. The exact cause is not known, but a disturbance of the motor system is hypothesised, probably related to various causes such as loss of cortical inhibition or problems with sensory input. Neuroimaging studies have shown hyperactivity in various brain regions during speech production in patients with AdSD, but it is still unclear whether this hyperactivity is due to a malfunction of auditory and somatosensory feedback or an impairment of motor programming. Recent research indicates that patients with AdSD show excessive muscle activation during phonation, probably due to abnormal processing of auditory feedback. This suggests that intervention in the auditory system may offer new treatment opportunities. The proposed study aims to describe the acoustic, auditory-perceptual and subjective voice and speech changes in AdSD subjects during the Quick-Lombard Test (LT), a test that assesses vocal response under noisy conditions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06402214
Study type Interventional
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact Maria Raffaella Marchese, MD, PhD
Phone +39-3391144556
Email raffaellamarchese@gmail.com
Status Not yet recruiting
Phase N/A
Start date May 1, 2024
Completion date May 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05158166 - DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia Phase 1/Phase 2
Enrolling by invitation NCT03129087 - The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia N/A
Completed NCT03349086 - Effects of Vocal Exercises for Spasmodic Dysphonia N/A
Completed NCT02528006 - Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges Phase 2/Phase 3
Not yet recruiting NCT05467228 - Laryngeal Vibro-tactile Stimulation as a Non-invasive Symptomatic Treatment for Spasmodic Dysphonia Phase 2
Completed NCT05158179 - Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia N/A